MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
About this item
Full title
Author / Creator
Vescarelli, Enrica , Gerini, Giulia , Megiorni, Francesca , Anastasiadou, Eleni , Pontecorvi, Paola , Solito, Luciana , De Vitis, Claudia , Camero, Simona , Marchetti, Claudia , Mancini, Rita , Benedetti Panici, Pierluigi , Dominici, Carlo , Romano, Ferdinando , Angeloni, Antonio , Marchese, Cinzia and Ceccarelli, Simona
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Ovarian cancer (OC) is the most lethal gynecological malignancy and the second leading cause of cancer-related death in women. Treatment with PARP inhibitors (PARPi), such as Olaparib, has been recently introduced for OC patients, but resistance may occur and underlying mechanisms are still poorly understood. The aim of this study is to identify ta...
Alternative Titles
Full title
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_44a1df77c3704f56baee7d518d8349e0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_44a1df77c3704f56baee7d518d8349e0
Other Identifiers
ISSN
1756-9966,0392-9078
E-ISSN
1756-9966
DOI
10.1186/s13046-019-1490-7
